Because Heart Matters!

Welcome to Klavant – precision in healthcare

Intraoperative visualization and measurement for cardiac surgery

Klavant develops medical technology to support the visualization, assessment and measurement of anatomical structures during surgery.

Klavant is building technology for intraoperative visualization and quantitative assessment in cardiac surgery. Our focus is to support surgeons with better visual and metric information during procedures, where decisions are still often based primarily on experience and visual estimation.

Critical decisions still rely heavily on visual estimation

In many surgical settings, intraoperative assessment of anatomical structures remains highly experience-driven.

While imaging and planning tools have advanced significantly, quantitative information available directly during the procedure is often limited.

This creates a gap between preoperative planning and intraoperative decision-making.

Klavant addresses the lack of structured visual and metric information directly in the operating room. The aim is to support intraoperative assessment with a more objective basis for surgical evaluation and decision-making.

Technology designed to support intraoperative assessment

Klavant develops technology to improve the intraoperative visualization and measurement of anatomical structures. The goal is to provide surgeons with structured visual and metric information during the procedure and to support assessment directly in the surgical workflow.

Improved intraoperative visualization – Designed to support the visual assessment of relevant anatomical structures directly in the OR.
Quantitative intraoperative information – Supports the measurement and structured assessment of anatomy during the procedure.
Built for surgical workflows – Developed to integrate into the intraoperative environment and support decision-making without disrupting existing clinical processes.

Development and milestones

Klavant is currently advancing its technology through development and preclinical evaluation.

With the successful EN ISO 13485 certification of our quality management system, we have achieved an important milestone in our journey towards MDR conformity assessment and CE marking.

Certain advanced functionalities remain part of ongoing research and are not part of current routine clinical use. The company has successfully completed a project funded by the German Federal Ministry of Education and Research (BMBF) and is progressing development, verification and documentation as part of the next certification-oriented phase.

Project funded by the German Federal Ministry of Education and Research (BMBF)
Participant of Creative Destruction Lab (CDL) Berlin
Ongoing preclinical evaluation
EN ISO 13485 certified quality management system

News

10/26 – Klavant achieves EN ISO 13485 certification

04/26 – Successful completion of the KMU-innovativ project.

10/25 – As part of the EACTS society, Klavant participates in the 39th annual meeting in Copenhagen.

10/24 – Klavant joins the prestigious Creative Destruction Lab Berlin program, paving the way for exciting advancements in healthcare innovation.

10/23 – We are excited to share our latest press release, which marks an important milestone.

Find out more

innovative and digital

new insights

performance measurement

14.02.2025

KLAVANT RECEIVES EU SEAL OF EXCELLENCE

Klavant’s project proposal was recognized by the European Commission as a high-quality innovation project within the highly competitive Horizon Europe EIC Accelerator evaluation process.

Find out more

20.11.2020

Klavant is winner of ideas phase at Science4Life Venture Cup!

In the highly renowned Germany-wide Science4Life competition, which has been held for over 20 years, Klavant was awarded winner of the ideas phase in the Life Science Venture Cup category among around 60 participants.

Find out more

17.11.2020

1st place in the MedTech Business Plan 2020 competition

Klavant won the prestigious German medical technology business plan competition 2020 among approx. 50 applicants and 11 finalists. The participants qualified for the finals in a multi-stage process over half a year. Around 60 experts were involved in evaluating the participating startups.

Find out more

28.10.2020

2nd place at VENTURE.Med 2020 competition

At the hybrid startup pitching competition VENTURE.Med 2020 organized by Business Angel Network Germany and the initiatives ProRuhrgebiet and Digital Economy of NRW, Klavant won the 2nd place. From around 60 participants, the 30-person screening committee selected the TOP 10 as finalists, who were able to present their business ideas in Cologne. Klavant convinced both the expert panel on site and the more than 100 investors who took part in the event online and who were able to vote for their favorites.

Find out more

Interested in clinical partnerships or receiving our abstract?

Please contact us:
info(at)klavant.de
Phone: +49 (0) 571 / 783 419 – 0

Contact

EN ISO 13485 Certified

Legal notice